At a glance
- Originator Nonindustrial source
- Class Cytostatics; Depsipeptides
- Mechanism of Action Apoptosis stimulants; Mitosis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer